AnteoTech: Half Yearly Report and Accounts
Filed with ASX · · 24 pages · English
Summary by 6ix AI
The report indicates a significant decrease in revenues from ordinary activities, alongside a notable reduction in the loss after tax compared to the previous period. The report also highlights a successful capital raise to support future growth initiatives and strategic partnerships.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from AnteoTech
- Quarterly Activities/Appendix 4C Cash Flow Report
- AnteoTech $3.5m Capital Raising
- Trading Halt
- AnteoBind order received and Life Sciences Update
- Ultranode X achieves more than 1,000 Cycles at 80% Capacity
Later from AnteoTech
- Ultranode 95 validated in cell format suited for drone use
- Underwriting of Listed Options
- New Product- Anteo C - launched and Shipped for Scale Trials
- Anteo S Strategic Collaboration and Sales Agreement Executed
- ADLM 2026 Expands Life Sciences Sales Pipeline
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech